A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors (PRIMROSE)
NCT 06130553 Brief Summary This is a first time in human (FTiH)…
Read more arrow_forwardNCT 06130553 Brief Summary This is a first time in human (FTiH)…
Read more arrow_forwardNCT 05468697 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04771130 Brief Summary The study will determine the safety, tolerability, recommended…
Read more arrow_forwardNCT 05381909 Brief Summary This study aims to understand how safe and…
Read more arrow_forwardNCT 05935098 Brief Summary This study aims to test the safety, tolerability,…
Read more arrow_forwardNCT 06803680 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 05774951 Brief Summary This is a Phase III open-label study…
Read more arrow_forwardNCT 05346484 Brief Summary This is an open-label, dose-escalation, multi-center phase I…
Read more arrow_forwardNCT 06550895 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05117476 Brief Summary CLN-619-001 is a Phase 1, open-label, multi-center study…
Read more arrow_forward